These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9519234)

  • 1. Is high-dose fluticasone propionate via a metered-dose inhaler and Volumatic as efficacious as nebulized budesonide in adult asthmatics?
    O'Reilly JF; Weir DC; Banham S; Basran GS; Boyd G; Patel KR
    Respir Med; 1998 Jan; 92(1):111-7. PubMed ID: 9519234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High dose fluticasone propionate, 1 mg daily, versus fluticasone propionate, 2 mg daily, or budesonide, 1.6 mg daily, in patients with chronic severe asthma. International Study Group.
    Ayres JG; Bateman ED; Lundbäck B; Harris TA
    Eur Respir J; 1995 Apr; 8(4):579-86. PubMed ID: 7664857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of patient-reported outcomes during treatment with adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler versus fixed-dose fluticasone propionate/salmeterol dry powder inhaler in patients with asthma.
    O'Connor RD; Patrick DL; Parasuraman B; Martin P; Goldman M
    J Asthma; 2010 Mar; 47(2):217-23. PubMed ID: 20170333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
    Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
    Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenocortical activity with repeated twice daily dosing of fluticasone propionate and budesonide given via a large volume spacer to asthmatic school children.
    Lipworth BJ; Clark DJ; McFarlane LC
    Thorax; 1997 Aug; 52(8):686-9. PubMed ID: 9337826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nebulized fluticasone propionate vs. budesonide as adjunctive treatment in children with asthma exacerbation.
    De Benedictis FM; Del Giudice MM; Vetrella M; Tressanti F; Tronci A; Testi R; Dasic G;
    J Asthma; 2005 Jun; 42(5):331-6. PubMed ID: 16116682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-efficacy comparison of inhaled fluticasone propionate and budesonide in the treatment of asthma.
    Stempel DA; Stanford RH; Thwaites R; Price MJ
    Clin Ther; 2000 Dec; 22(12):1562-74. PubMed ID: 11192147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-blind dose reduction study to compare the minimal effective dose of budesonide Turbuhaler and fluticasone propionate Diskhaler.
    Agertoft L; Pedersen S
    J Allergy Clin Immunol; 1997 Jun; 99(6 Pt 1):773-80. PubMed ID: 9215245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of high-dose fluticasone propionate and budesonide on lung function and asthma exacerbations in patients with severe asthma.
    Heinig JH; Boulet LP; Croonenborghs L; Möllers MJ
    Respir Med; 1999 Sep; 93(9):613-20. PubMed ID: 10542974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
    FitzGerald JM; Boulet LP; Follows RM
    Clin Ther; 2005 Apr; 27(4):393-406. PubMed ID: 15922813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluticasone propionate compared with budesonide: a double-blind trial in asthmatic children using powder devices at a dosage of 400 microg x day(-1).
    Hoekx JC; Hedlin G; Pedersen W; Sorva R; Hollingworth K; Efthimiou J
    Eur Respir J; 1996 Nov; 9(11):2263-72. PubMed ID: 8947070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the efficacy and safety of a half dose of fluticasone propionate with beclamethasone dipropionate and budesonide in childhood asthma.
    Karakoç F; Karadag B; Kut A; Ersu R; Bakaç S; Cebeci D; Dagli E
    J Asthma; 2001 May; 38(3):229-37. PubMed ID: 11392363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral steroid-sparing effect of two doses of nebulized fluticasone propionate and placebo in patients with severe chronic asthma.
    Westbroek J; Saarelainen S; Laher M; O'Brien J; Barnacle H; Efthimiou J
    Respir Med; 1999 Oct; 93(10):689-99. PubMed ID: 10581657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of high-dose inhaled steroids in children with asthma: a comparison of fluticasone propionate with budesonide.
    Ferguson AC; Spier S; Manjra A; Versteegh FG; Mark S; Zhang P
    J Pediatr; 1999 Apr; 134(4):422-7. PubMed ID: 10190915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical experience with fluticasone propionate in asthma: a meta-analysis of efficacy and systemic activity compared with budesonide and beclomethasone dipropionate at half the microgram dose or less.
    Barnes NC; Hallett C; Harris TA
    Respir Med; 1998 Jan; 92(1):95-104. PubMed ID: 9519232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salmeterol/fluticasone propionate (50/500 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in the treatment of steroid-dependent asthma.
    Aubier M; Pieters WR; Schlösser NJ; Steinmetz KO
    Respir Med; 1999 Dec; 93(12):876-84. PubMed ID: 10653049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of salmeterol/fluticasone propionate combination product 50/250 microg twice daily and budesonide 800 microg twice daily in the treatment of adults and adolescents with asthma. International Study Group.
    Lundbäck B; Jenkins C; Price MJ; Thwaites RM
    Respir Med; 2000 Jul; 94(7):724-32. PubMed ID: 10926346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salmeterol/fluticasone propionate combination therapy 50/250 microg twice daily is more effective than budesonide 800 microg twice daily in treating moderate to severe asthma.
    Jenkins C; Woolcock AJ; Saarelainen P; Lundback B; James MH
    Respir Med; 2000 Jul; 94(7):715-23. PubMed ID: 10926345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of salmeterol/fluticasone propionate versus fluticasone propionate in asthma patients: a randomized, double-blind study.
    Lee YS; Lin HC; Huang CD; Lee KY; Liu CY; Yu CT; Wang CH; Kuo HP
    Chang Gung Med J; 2011; 34(4):382-94. PubMed ID: 21880193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ease of handling and clinical efficacy of fluticasone propionate Accuhaler/Diskus inhaler compared with the Turbohaler inhaler in paediatric patients. UK Study Group.
    Williams J; Richards KA
    Br J Clin Pract; 1997; 51(3):147-53. PubMed ID: 9293055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.